The medication digoxin is a second-line agent for ventricular rate control in thyrotoxicosis-induced atrial fibrillation. It is reduced as hyperthyroidism is corrected. Serum digoxin levels should be kept below 1.2 ng/mL, since higher levels are associated with increased mortality.